Latest Insights on BMY
Buy This $140 Billion Pharma Powerhouse Stock NowI asked Brian Christopher to share his thoughts on what to expect going forward for this innovative pharmaceutical company.
Tell Us About Your Financial DreamsEveryone has financial dreams. And thanks to our experts’ stock recommendations this year, Sovereign Investor Daily readers like you are closer than ever to achieving them.
Grab 20% Gains From Pharma Powerhouse Bristol-Myers SquibbWhen the market is falling, you should see it as an opportunity to buy stocks for cheap … then reap the rewards once the Fed steps in.
The Experts Are Jumping Into This Way-Too-Cheap StockTwo of my favorite gurus confirmed my thoughts on this heavily discounted stock. They jumped into it in the first quarter.